390 Views

Session: Still the One? Debating Vancomycin as First-Line MRSA Agent in New Era of AUC/MIC Dosing and Monitoring

818 - Pro: Vancomycin Is Still the One

Friday, October 21, 2022

8:00 AM – 8:30 AM US ET

Location: 147 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Speaker(s)

Marc H. Scheetz, PharmD, MSc

Professor and Director of Pharmacometrics Center of Excellence
Midwestern University
Downers Grove, Illinois, United States

Disclosure: Disclosure(s): Abbvie: Advisor/Consultant (); Allecra: Grant/Research Support (); Merck: Advisor/Consultant (); Nevakar: Advisor/Consultant (), Grant/Research Support (); Premier Healthcare Solutions: Honoraria (); Spero: Advisor/Consultant (); SuperTrans Medical: Advisor/Consultant (), Grant/Research Support (); Takeda: Advisor/Consultant (); Third Pole Therapeutics: Advisor/Consultant ()

Disclosure(s):

Marc H. Scheetz, PharmD, MSc: Abbvie: Advisor/Consultant (); Allecra: Grant/Research Support (); Merck: Advisor/Consultant (); Nevakar: Advisor/Consultant (), Grant/Research Support (); Premier Healthcare Solutions: Honoraria (); Spero: Advisor/Consultant (); SuperTrans Medical: Advisor/Consultant (), Grant/Research Support (); Takeda: Advisor/Consultant (); Third Pole Therapeutics: Advisor/Consultant ()